What is the appropriate management of hyponatremia?

Management of Hyponatremia

The management of hyponatremia is determined primarily by symptom severity and acuity, with severely symptomatic patients requiring immediate hypertonic saline boluses to increase sodium by 4-6 mmol/L within 1-2 hours, while asymptomatic or mildly symptomatic patients are managed based on volume status with fluid restriction, normal saline, or treatment of underlying causes. 1

Initial Diagnostic Evaluation

When serum sodium is <131 mmol/L, immediately obtain: 1

• Serum and urine osmolality
• Urine sodium and electrolytes
• Serum uric acid
• Clinical assessment of extracellular fluid (ECF) volume status

Volume status assessment is critical and categorizes patients into hypovolemic, euvolemic, or hypervolemic hyponatremia, which directly determines treatment approach. 1

Severity Classification and Symptom-Based Treatment

Severely Symptomatic Hyponatremia (Medical Emergency)

Severe symptoms include seizures, coma, altered mental status, or cardiorespiratory distress and indicate cerebral edema requiring immediate intervention. 1, 2

Treatment protocol: 1

• Administer 3% hypertonic saline as 100-150 mL IV bolus (can repeat if needed)
• Target: Increase sodium by 4-6 mmol/L within 1-2 hours or until severe symptoms resolve
• Transfer to ICU with Q2hr sodium monitoring
• Critical correction limit: Do not exceed 8 mmol/L increase in first 24 hours (if 6 mmol/L corrected in 6 hours, limit additional correction to 2 mmol/L over next 18 hours)

The rationale for this aggressive approach is supported by retrospective data showing increased mortality with slower correction in severe hyponatremia (sodium <115 mmol/L): survivors had sodium of 127.1 mmol/L at 48 hours versus 118.8 mmol/L in those who died (P=0.0016). 1

Mildly Symptomatic Hyponatremia

Mild symptoms include nausea, vomiting, weakness, headache, or mild neurocognitive deficits. 2, 3

Treatment approach: 1

• Transfer to intermediate care unit
• Q4hr sodium monitoring
• Fluid restriction to 1 L/day initially
• Consider oral sodium chloride 100 mEq TID if no response
• High protein diet

Asymptomatic Hyponatremia

Treatment is based entirely on volume status and underlying etiology. 1, 2

Volume Status-Based Management

Hypovolemic Hyponatremia

Caused by: Extrarenal losses (vomiting, diarrhea) or intrarenal losses (cerebral salt wasting, diuretics, adrenal insufficiency). 1

Treatment: 3

• Normal saline (0.9% NaCl) infusions to restore volume
• For cerebral salt wasting specifically: Add fludrocortisone 0.1-0.2 mg daily for 7 days plus hypertonic saline if symptomatic 1

Euvolemic Hyponatremia (SIADH)

Diagnosis requires: Rule out thyroid disease, hypocortisolism, and polydipsia before confirming SIADH. 1

Treatment hierarchy: 1, 4

1. First-line: Fluid restriction 500 mL-1 L/day with adequate solute intake (salt and protein)
2. Second-line (if fluid restriction fails in ~50% of patients):
   • Oral urea (considered very effective and safe) 4
   • Vaptans (vasopressin receptor antagonists) - effective but risk overly rapid correction and increased thirst 2, 5
   • Loop diuretics 5

Note: Measuring ADH and natriuretic peptide levels is not supported by evidence and should not be routinely obtained. 1

Hypervolemic Hyponatremia

Caused by: Heart failure, cirrhosis, or renal failure. 1

Treatment: 3

• Treat underlying condition (heart failure, cirrhosis management)
• Free water restriction
• Consider vaptans in heart failure patients 2

Critical Correction Rate Principles

Acute Hyponatremia (<48 hours)

Can tolerate more rapid correction at rates up to 1 mmol/L/hour if severely symptomatic. 1

Chronic Hyponatremia (>48 hours)

Must avoid rapid correction to prevent osmotic demyelination syndrome. 1, 6

Safe correction targets: 6

• 6-8 mmol/L in 24 hours
• 12-14 mmol/L in 48 hours
• 14-16 mmol/L in 72 hours
• Never exceed 10 mmol/L in 24 hours, 18 mmol/L in 48 hours, or 20 mmol/L in 72 hours

Managing Inadvertent Overcorrection

If unwanted water diuresis causes overly rapid correction: 6

• Administer desmopressin immediately to terminate water diuresis
• Give hypotonic fluids
• Frequent monitoring is mandatory (every 2-4 hours initially)

This complication can occur with any therapy, including vaptans, making vigilant monitoring essential. 6

Special Populations

Subarachnoid Hemorrhage Patients

Treat even at sodium levels 131-135 mmol/L due to risk of vasospasm with triple-H therapy (hypervolemia, hypertension, hemodilution). 1

Sodium <120 mmol/L

Classified as severe hyponatremia requiring more aggressive monitoring and treatment consideration regardless of symptoms. 1

Common Pitfalls

Overcorrection risk: Occurs in 4.5-28% of treated patients and can cause irreversible osmotic demyelination syndrome with parkinsonism, quadriparesis, or death. 2, 6

Fluid restriction failure: Nearly 50% of SIADH patients do not respond to fluid restriction alone, necessitating second-line therapy. 4

Volume status misassessment: Incorrectly categorizing volume status leads to inappropriate treatment (e.g., fluid restriction in hypovolemic patient). 1

Recent Evidence on Outcomes

A 2026 randomized trial of 2,173 hospitalized patients found that targeted hyponatremia correction achieved higher normonatremia rates (60.4% vs 46.2%) but did not reduce 30-day mortality or rehospitalization compared to routine care (20.5% vs 21.8%, P=0.45). 7 This suggests that while correcting hyponatremia is important for symptom management and preventing complications, hyponatremia may be more of a marker of disease severity than an independent driver of mortality in chronic cases.

However, chronic mild hyponatremia still causes significant morbidity including increased falls (23.8% vs 16.4%), fractures (23.3% vs 17.3% over 7.4 years), cognitive impairment, and gait disturbances, justifying treatment to improve quality of life. 2